PFE Operating Cash Flow (Statement)

Pfizer · Operating Cash Flow (Statement)

PFE logo

PFE Operating Cash Flow (Statement)

Latest reported$13.40B
PFE TTM Cash from Operations ($860.50M → $13.40B)
High-resolution chart · PNG

PFE operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pfizer Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
13,402,000,000
11,985,000,000
11,705,000,000
13,077,000,000
15,188,000,000
13,989,000,000
12,744,000,000
11,263,000,000
8,005,000,000
8,577,000,000
8,700,000,000
12,042,000,000
14,560,000,000
23,938,000,000
29,266,000,000
26,598,000,000
31,453,000,000
34,583,000,000
32,580,000,000
32,291,000,000
23,552,000,000
15,808,000,000
14,403,000,000
12,547,000,000
14,967,000,000
14,023,000,000
12,588,000,000
13,557,000,000
14,306,000,000
15,542,000,000
15,827,000,000
17,831,000,000
17,459,000,000
16,864,000,000
16,470,000,000
15,700,000,000
15,512,000,000
15,839,000,000
15,901,000,000
14,642,000,000
14,967,000,000
15,478,000,000
14,512,000,000
15,197,000,000
14,636,000,000
14,633,000,000
16,883,000,000
17,271,000,000
18,716,000,000
18,459,000,000
17,765,000,000
17,235,000,000
16,330,000,000
16,521,000,000
17,054,000,000
17,059,000,000
16,495,000,000
18,372,000,000
20,240,000,000
21,237,000,000
23,481,000,000
22,456,000,000
11,454,000,000
10,021,000,000
7,439,000,000
7,080,000,000
16,587,000,000
17,735,000,000
17,586,000,000
18,114,000,000
18,238,000,000
16,032,000,000
16,758,000,000
15,381,000,000
13,353,000,000
14,062,000,000
13,398,000,000
14,876,000,000
17,594,000,000
17,855,000,000
16,854,000,000
15,520,000,000
14,733,000,000
15,986,000,000
18,149,000,000
17,931,000,000
16,340,000,000
14,746,000,000
12,443,000,000
10,985,000,000
11,739,000,000
11,077,000,000
10,519,000,000
10,946,000,000
10,183,000,000
8,922,000,000
9,187,000,000
9,023,000,000
9,263,000,000
9,440,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.